Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 21, Issue 1, 2009, Pages 70-77

  DeSilva, Malini B ^a   Merry, Stephen P ^b   Fischer, Philip R ^b   Rohrer, James E ^b   Isichei, Christian O ^c   Cha, Stephen S ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF JOS   (Nigeria)

Author keywords

Gender; HAART; HIV; Mortality; Nigeria

Indexed keywords

LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; AIDS PATIENT; ARTICLE; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; JUVENILE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NIGERIA; OCCUPATION; PREDICTION; PRIORITY JOURNAL; TUBERCULOSIS; UNEMPLOYMENT;

ADOLESCENT; ADULT; AGE FACTORS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; HIV INFECTIONS; HUMANS; MALE; NIGERIA; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TUBERCULOSIS; UNEMPLOYMENT;

EID: 57649123259     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120802017636     Document Type: Article

References (33)

1. Alubo, O., Zwandor, A., Jolayemi, T., & Omudu, E. (2002). Acceptance and stigmatization of PLWA in Nigeria. AIDS Care, 14(1), 117-126.
2. Badri, M., Bekker, L.G., Orrell, C., Pitt, J., Cilliers, F., & Wood, R. (2004). Initiating highly active antiretroviral therapy in sub-Saharan Africa: An assessment of the revised World Health Organization scaling-up guidelines. AIDS, 18(8), 1159-1168.
3. Boerma, J.T., Nunn, A.J., & Whitworth, J.A. (1998). Mortality impact of the AIDS epidemic: Evidence from community studies in less developed countries. AIDS, 12(Suppl. 1), S3-S14.
4. Braitstein, P., Brinkhof, M.W., Dabis, F., Schechter, M., Boulle, A., Miotti, P., et al. (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet, 367(9513), 817-824.
5. Cole, S.R., Hernan, M.A., Margolick, J.B., Cohen, M.H., & Robins, J.M. (2005). Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. American Journal of Epidemiology, 162(5), 471-478.
6. Collazos, J., Asensi, V., & Carton, J.A. (2007). Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. AIDS, 21(7), 835-843.
7. Duncombe, C., Kerr, S.J., Ruxrungtham, K., Dore, G.J., Law, M.G., Emery, S., et al. (2005). HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting. AIDS, 19(2), 169-178.
8. Egger, M., May, M., Chene, G., Phillips, A.N., Ledergerber, B., Dabis, F., et al. (2002). Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet, 360(9327), 119-129.
9. Federal Ministry of Health, Department of Public Health, National AIDS/STDs Control Programme. (2004). 2003 National HIV Sero-prevalence Sentinel Survey Accessed December 9, 2006, available at: http://www.nigeria-aids.org/pdf/2003SentinelSurvey.pdf
10. Frater, A.J., Dunn, D.T., Beardall, A.J., Ariyoshi, K., Clarke, J.R., McClure, M.O., et al. (2002). Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. AIDS, 16(8), 1139-1146.
11. Garcia de la Hera, M., Ferreros, I., del Amo, J., Garcia de Olalla, P., Perez Hoyos, S., Muga, R., et al. (2004). Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001. Journal of Epidemiology and Community Health, 58(11), 944-950.
12. Hardon, A.P., Akurut, D., Comoro, C., Ekezie, C., Irunde, H.F., Gerrits, T., et al. (2007). Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS Care, 19(5), 658-665.
13. Hogg, R.S., Heath, K.V., Yip, B., Craib, K.J., O'Shaughnessy, M.V., Schechter, M.T., et al. (1998). Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA, 279(6), 450-454.
14. Hogg, R.S., Yip, B., Chan, K.J., Wood, E., Craib, K.J., O'Shaughnessy, M.V., et al. (2001). Rates of disease progression by baseline CD4 cell count andviral load after initiating triple-drug therapy. JAMA, 286(20), 2568-2577.
15. Lemp, G.F., Payne, S.F., Neal, D., Temelso, T., & Rutherford, G.W. (1990). Survival trends for patients with AIDS. JAMA, 263(3), 402-406.
16. Lucas, S.B., Hounnou, A., Peacock, C., Beaumel, A., Djomand, G., N'Gbichi, J.M., et al. (1993). The mortality and pathology of HIV infection in a west African city. AIDS, 7(12), 1569-1579.
17. Luginaah, I.N., Yiridoe, E.K., & Taabazuing, M.M. (2005). From mandatory to voluntary testing: Balancing human rights, religious and cultural values, and HIV/AIDS prevention in Ghana. Social Science & Medicine, 61(8), 1689-1700.
18. Mayor, A.M., Gomez, M.A., Rios-Oliveras, E., & Hunter-Mellado, R.F. (2005). Mortality trends of HIV-infected patients after the introduction of highly active antiretroviral therapy: Analysis of a cohort of 3,322 HIV-infected persons. Ethnicity & Disease. 15(4 Suppl. , -62, 5), S5-57.
19. Melnick, S.L., Sherer, R., Louis, T.A., Hillman, D., Rodriguez, E.M., Lackman, C., et al. (1994). Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS. JAMA, 272(24), 1915-1921.
20. Mills, E.J., Nachega, J.B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., et al. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA, 296(6), 679-690.
21. Moore, A.L., Sabin, C.A., Johnson, M.A., & Phillips, A.N. (2002). Gender and clinical outcomes after starting highly active antiretroviral treatment: A cohort study. Journal of Acquired Immune Deficiency Syndrome, 29(2), 197-202.
22. Moore, R.D., Cheever, L., Keruly, J.C., & Chaisson, R.E. (1999). Lack of sex difference in CD4 to HIV-1 RNA viral loadratio. Lancet, 353(9151), 463-464.
23. Napravnik, S., Poole, C., Thomas, J.C., & Eron, J.J., Jr. (2002). Gender difference in HIV RNA levels: A meta-analysis of published studies. Journal of Acquired Immune Deficiency Syndrome, 31(1), 11-19.
24. Nicastri, E., Angeletti, C., Palmisano, L., Sarmati, L., Chiesi, A., Geraci, A., et al. (2005). Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS, 19(6), 577-583.
25. Office of US Global AIDS Coordinator and the Bureau of Public Affairs. (2006). The United States President's Emergency Plan for AIDS Relief. RetrievedAugust 20, 2007, from http://www.pepfar.gov/about/.
26. Palella, F.J., Jr., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338(13), 853-860.
27. Saah, A.J., Hoover, D.R., He, Y., Kingsley, L.A., & Phair, J.P. (1994). Factors influencing survival after AIDS: Report from the Multicenter AIDS Cohort Study (MACS). Journal of Acquired Immune Deficiency Syndrome, 7(3), 287-295.
28. Sani, M.U., Mohammed, A.Z., Adamu, B., Yusuf, S.M., Samaila, A.A., & Borodo, M.M. (2006). AIDS mortality in a tertiary health institution: A four-year review. Journal of the National Medical Association, 98(6), 862-866.
29. Shafer, R.W., Bloch, A.B., Larkin, C., Vasudavan, V., Seligman, S., Dehovitz, J.D., et al. (1996). Predictors of survival in HIV-infected tuberculosis patients. AIDS, 10(3), 269-272.
30. Spino, C., Kahn, J.O., Dolin, R., & Phair, J.P. (1997). Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 15(5), 346-355.
31. St Lawrence, J.S., Marx, B.P., Scott, C.P., Uwakwe, C.B., Roberts, A., & Brasfield, T.L. (1995). Cross-cultural comparison of US and Nigerian adolescents' HIV-related knowledge, attitudes, and risk behaviour: Implications for risk reduction interventions. AIDS Care, 7(4), 449-461.
32. Stringer, J.S., Zulu, I., Levy, J., Stringer, E.M., Mwango, A., Chi, B.H., et al. (2006). Rapidscale-up of antiretroviral therapy at primary care sites in Zambia: Feasibility andearly outcomes. JAMA, 296(7), 782-793.
33. Thacher, T.D., Fischer, P.R., Pettifor, J.M., Lawson, J.O., Isichei, C.O., & Chan, G.M. (2000). Case-control study of factors associated with nutritional rickets in Nigerian children. Journal of Pediatrics, 137(3), 367-373.